Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease

scientific article

Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2265.2004.02018.X
P698PubMed publication ID15104557
P5875ResearchGate publication ID8599577

P50authorKatharina SunnerhagenQ28871736
Gudmundur JohannssonQ38546682
P2093author name stringJohan Svensson
P2860cites workGender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiencyQ30716787
Incidence and late prognosis of cushing's syndrome: a population-based studyQ33936344
The diagnosis of growth hormone deficiency in children and adultsQ41756388
A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indicesQ43766396
Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset diseaseQ43902744
Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.Q50936953
Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test.Q50945514
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.Q51561776
Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength.Q53862981
P433issue5
P921main subjectgrowth hormone deficiencyQ369262
Hormone Replacement TherapyQ108667313
P304page(s)550-559
P577publication date2004-05-01
P1433published inClinical EndocrinologyQ15762781
P1476titleBaseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease
P478volume60

Reverse relations

cites work (P2860)
Q37953199Adipokines and cardiovascular risk in Cushing's syndrome
Q38015162Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications
Q38004913Clinical consequences of Cushing's syndrome
Q46419684Final adult height and body mass index after cure of paediatric Cushing's disease
Q37072338Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
Q27002329GH and the cardiovascular system: an update on a topic at heart
Q37201576Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas
Q37644244Psychosomatic aspects of Cushing's syndrome
Q48495807Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.
Q37103765The pituitary-adrenal axis and body composition

Search more.